GENEVA, April 1 -- SLBIGEN INC. (85, Songdogwahak-roYeonsu-guIncheon 21983), 주식회사 에스엘바이젠 (인천광역시연수구송도과학로 85), GI INNOVATION, INC. (A-1116, 167, Songpa-daeroSongpa-guSeoul 05855), (주)지아이이노베이션 (서울특별시송파구송파대로 167, 에이동 1116호) filed a patent application (PCT/KR2024/014224) for "NOVEL CANCER THERAPEUTIC AGENT COMPRISING ANTICANCER DNA VACCINE AND IMMUNE RESPONSE-ENHANCING FUSION PROTEIN" on Sep 20, 2024. With publicati...